Table 3.

The 10 Most Frequently Observed PIMs

PIM DescriptionPercentage of Total PIMs (N = 56,605)a
  1.Stop benzodiazepines (sedative, may cause reduced sensorium, impair balance)15.7
  2.Stop benzodiazepines taken for ≥4 weeks (no indication for longer treatment; risk of prolonged sedation, confusion, impaired balance, falls, road traffic accidents; all benzodiazepines should be withdrawn gradually if taken for >4 weeks as there is a risk of causing a benzodiazepine withdrawal syndrome if stopped abruptly)11.9
  3.Stop drugs likely to cause constipation (eg, antimuscarinic/anticholinergic drugs, oral iron, opioids, verapamil, aluminum antacids) in patients with chronic constipation where nonconstipating alternatives are available (risk of exacerbation of constipation)  5.1
  4.Aspirin, clopidogrel, dipyridamole, vitamin K antagonists, direct thrombin inhibitors, or factor Xa inhibitors with concurrent substantial bleeding risk, that is, uncontrolled severe hypertension, bleeding diathesis, recent nontrivial spontaneous bleeding (high risk of bleeding)  4.6
  5.Stop PPI for uncomplicated peptic ulcer disease or erosive peptic esophagitis at full therapeutic dosage for >8 weeks (dose reduction or earlier discontinuation indicated)  4.5
  6.Stop colchicine if eGFR <10 mL/min/1.73m2 (risk of colchicine toxicity)  4.0
  7.Stop NSAIDs if eGFR <50 mL/min/1.73m2 (risk of deterioration in renal function)  3.6
  8.Stop use of oral or transdermal strong opioids (morphine, oxycodone, fentanyl, buprenorphine, diamorphine, methadone, tramadol, pethidine, pentazocine) as first-line therapy for mild pain (WHO analgesic ladder not observed)  3.5
  9.Stop neuroleptic drugs (may cause gait dyspraxia, parkinsonism)  3.2
10.Stop hypnotic Z-drugs such as zopiclone, zolpidem, zaleplon (may cause protracted daytime sedation, ataxia)  3.2
  • eGFR = estimated glomerular filtration rate; NSAID = nonsteroidal anti-inflammatory drug; PIM = potentially inappropriate medication; PPI = proton pump inhibitor; WHO = World Health Organization.

  • Note: PIMs provide information on correct deprescribing according to the Screening Tool of Older Person’s Prescriptions (STOPP) criteria.

  • a Unique PIMs per patient over 6 years.